This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kenji Kashima: Innovator in Cancer Research
Introduction
Kenji Kashima is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of cancer research, particularly in understanding the sensitivity of cancer cells to specific inhibitors.
Latest Patents
Kashima holds a patent titled "Method for Predicting Sensitivity of Cancer Cell to GPX4 Inhibitor." This innovative method aims to enhance the effectiveness of cancer treatments by predicting how cancer cells respond to GPX4 inhibitors.
Career Highlights
Kashima is associated with Chugai Pharmaceutical Co., Ltd., where he has been instrumental in advancing cancer research. His work has garnered attention for its potential to improve therapeutic strategies in oncology.
Collaborations
Kashima has collaborated with notable colleagues, including Keisuke Hashimoto and Hiroshi Sakamoto. These partnerships have fostered a collaborative environment that enhances research outcomes.
Conclusion
Kenji Kashima's contributions to cancer research through his innovative patent and collaborations highlight his role as a key figure in the scientific community. His work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile